Maharashtra's plan to buy drug from Bangladesh irks local companies https://ift.tt/eA8V8J

Indian firms said that the Bangladeshi company with which Mantralaya is in talks has neither the import licence, nor a manufacturing licence from Gilead to sell the drug in India.

from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2XKsKSF